summary

Here are passages from the CAPLYTA PRESCRIBING INFORMATION and MEDICATION GUIDE which may be helpful to address your question:

Is it safe for elderly patients to take CAPLYTA?

CAPLYTA may cause serious side effects, including:

• Increased risk of death in elderly people with dementia related psychosis. Medicines like CAPLYTA can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). CAPLYTA is not approved for the treatment of people with dementia-related psychosis.¹ 
• Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death.¹ 
• Decreased blood pressure (orthostatic hypotension). You may feel lightheaded or faint when you rise too quickly from a sitting or lying position.¹ 
• Falls. CAPLYTA may make you sleepy or dizzy, may cause a decrease in your blood pressure when changing position (orthostatic hypotension), and can slow your thinking and motor skills which may lead to falls that can cause fractures or other injuries.¹ 
• Uncontrolled body movements (tardive dyskinesia). CAPLYTA may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking CAPLYTA. Tardive dyskinesia may also start after you stop taking CAPLYTA.¹
  • The risk appears to be highest among the elderly, particularly elderly women.¹ 

The use of serotonin reuptake inhibitors (SRIs) can cause low sodium in the blood, a condition called hyponatremia. Elderly patients are more likely to get this problem. Taking CAPLYTA at the same time as a serotonin reuptake inhibitor may make the risk of hyponatremia higher.¹  

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest use in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the MEDICATION GUIDE for CAPLYTA.¹